Beata Franczyk

ORCID: 0000-0003-4060-8822
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Dialysis and Renal Disease Management
  • Diet and metabolism studies
  • Chronic Kidney Disease and Diabetes
  • Lipoproteins and Cardiovascular Health
  • Diabetes Treatment and Management
  • Gut microbiota and health
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Cardiovascular Function and Risk Factors
  • Blood Pressure and Hypertension Studies
  • Pancreatic function and diabetes
  • Metabolism, Diabetes, and Cancer
  • Cancer, Lipids, and Metabolism
  • Renal cell carcinoma treatment
  • Erythropoietin and Anemia Treatment
  • Antioxidant Activity and Oxidative Stress
  • Pharmacogenetics and Drug Metabolism
  • Cardiac electrophysiology and arrhythmias
  • Liver Disease Diagnosis and Treatment
  • Nutritional Studies and Diet
  • Atherosclerosis and Cardiovascular Diseases
  • Cardiac Arrhythmias and Treatments
  • Heart Failure Treatment and Management
  • Electrolyte and hormonal disorders
  • Adipokines, Inflammation, and Metabolic Diseases
  • Parathyroid Disorders and Treatments

Medical University of Lodz
2016-2025

Anemia is one of the most common chronic kidney disease (CKD) complications. It negatively affects patients’ quality life and clinical outcomes. The pathophysiology anemia in CKD involves interplay various factors such as erythropoietin (EPO) deficiency, iron dysregulation, inflammation, bone marrow dysfunction, nutritional deficiencies. Despite recent advances understanding this condition, still remains a serious challenge population patients with CKD. Several guidelines have been published...

10.3390/biomedicines12061191 article EN cc-by Biomedicines 2024-05-27

Affecting millions of people worldwide, chronic kidney disease is a serious medical problem. It results in decrease glomerular filtration rate below 60 mL/min/1.73 m, albuminuria, abnormalities urine sediment and pathologies detected by imaging studies lasting minimum 3 months. Patients with CKD develop uremia, as result the accumulation uremic toxins body, patients can be expected to suffer from number consequences such progression renal fibrosis, development atherosclerosis or increased...

10.3390/antiox13060687 article EN cc-by Antioxidants 2024-06-03

Cardiovascular diseases stand as the predominant global cause of mortality, exerting a profound impact on both life expectancy and its quality. Given their immense public health burden, extensive efforts have been dedicated to comprehending underlying mechanisms developing strategies for prevention treatment. Selenium, crucial participant in redox reactions, emerges notable factor maintaining myocardial cell homeostasis influencing progression cardiovascular disorders. Some disorders, such...

10.3390/antiox13060688 article EN cc-by Antioxidants 2024-06-03

Primary electrical heart diseases, often considered channelopathies, are inherited genetic abnormalities of cardiomyocyte behavior carrying the risk malignant arrhythmias leading to sudden cardiac death (SCD). Approximately 54% sudden, unexpected deaths in individuals under age 35 do not exhibit signs structural disease during autopsy, suggesting potential significance channelopathies this group age. Channelopathies constitute a highly heterogenous comprising various diseases such as long QT...

10.3390/ijms25031826 article EN International Journal of Molecular Sciences 2024-02-02

Some of the most common conditions affecting people are kidney diseases. Among them, we distinguish chronic disease and acute injury. Both entities pose serious health risks, so new drugs still being sought to treat prevent them. In recent years, such a role has begun be assigned sodium-glucose cotransporter-2 (SGLT2) inhibitors. They increase amount glucose excreted in urine. For this reason, they currently used as first-line drug type 2 diabetes mellitus. Due their demonstrated...

10.3390/ijms25094959 article EN International Journal of Molecular Sciences 2024-05-01
Coming Soon ...